日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Pharma association issues report on innovative drugs

By Liu Zhihua | chinadaily.com.cn | Updated: 2021-04-21 17:44
Share
Share - WeChat
The Executive Committee of the Research & Development-based Pharmaceutical Association Committee under the China Association of Enterprises with Foreign Investment held an event on Tuesday to release a report on the innovative pharmaceutical industry and its role in the implementation of the Healthy China 2030 initiative. [Photo provided to chinadaily.com.cn]

A total of 200 innovative drugs have been approved in China over the past five years, among which many have been included in public-funded medical insurance programs, according to a recent report by the Executive Committee of the Research & Development-based Pharmaceutical Association Committee under the China Association of Enterprises with Foreign Investment.

Focusing on the innovative pharmaceutical industry and its role in the implementation of the Healthy China 2030 initiative, the report said about 33 percent of innovative drugs approved in the past five years are tumor treatments, and about 80 percent of the drugs, or 156 titles, are from multinational pharmaceutical companies.

The innovative drugs registered by multinational pharmaceutical companies have also showed more diversity in the past five years, as the share of tumor treatments has dropped to 33 percent from 47 percent in the period from 2010 to 2015, while more drugs for diseases related to the nervous system, digestion and the cardiovascular and respiratory systems have been registered.

Yang Ying, vice-president of Worldwide Business Development Asia at US-based pharmaceutical company Pfizer, said foreign pharmaceutical enterprises see China not only as an important market, but also an important investment destination for both commercialization and research and development.

As Chinese enterprises show increasing innovation capabilities, there are more cooperation opportunities for foreign and domestic enterprises in pharmaceutical industry, she said.

However, high costs and patients' lack of access to innovative drugs still remain a problem for the innovative pharmaceutical industry in China, according to the report.

Innovative drugs only account for about 9 percent of the total pharmaceutical market in China, the world's second-largest pharmaceutical market in the world, while in other G20 member countries the figure is all above 20 percent, and in developed countries such as the United States, Japan and Germany, the figure is more than 50 percent.

Kang Wei, managing director of RDPAC, suggested promoting the development of commercial insurance to increase the accessibility of innovative drugs and thus better meet Chinese patients' clinical demands.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 精品在线不卡 | 色播视频在线播放 | 国产精品尤物在线 | 狠狠色丁香婷婷综合橹不卡 | 亚洲一区在线观看视频 | 夜夜夜操 | 欧美三级视频在线播放 | 免费在线成人 | 国产婷婷精品av在线 | 在线一区视频 | 99成人免费视频 | 久久人人爽人人爽 | 国产视频大全 | jizz18毛片 | 日产国产欧美视频一区精品 | 精品一卡2卡三卡四卡二卡 欧美不卡一区二区三区在线观看 | 久久婷五月综合 | 日韩 欧美 亚洲国产 | 四虎影在线永久免费四虎地址8848aa | 久久精品在这里 | 男女xx | 精品在线一区 | 欧美调教视频 | 日韩二三区 | 色综合中文字幕天天在线 | 色综合亚洲天天综合网站 | 日本黄色小视频在线观看 | 中文成人在线 | 日本视频一区在线观看免费 | 免费人成年短视频在线观看免费网站 | 国产精品成人一区二区 | 天天艹夜夜 | 国产小视频在线播放 | 久久精品人人做人人 | 免费国产成人午夜在线观看 | 国产91在线 | 亚洲 | 免费黄色大片在线观看 | 污的视频在线观看 | 日韩欧美国产精品第一页不卡 | 福利视频第一页 | 日韩午夜三级 |